Uihlein Richard E

Uihlein Richard E is listed in filings as Director, 10% Owner at Galectin Therapeutics Inc.. This profile follows SEC Form 4 activity through Jan 21, 2026, including 4 public disclosures. Recent filings connect the profile to Galectin Therapeutics Inc. (GALT). The current snapshot covers public activity from Jan 27, 2025 to Jan 21, 2026. Reported amounts are shown as $73.8K to $182.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.